LYTIR

Insider · SEC Form 4 · PRESIDENT & CEO

Nikhil Lalwani

Filed with the SEC as Lalwani Nikhil; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $1.2M of ANIP. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.2M in total.Aug: Insider sales $401KSep: Insider sales $383KOct: Insider sales $388KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. ANIPSold: ANI PHARMACEUTICALS INC Oct 15, 2026 5,400 shares filed Oct 16, 2026 333,689 shares held directly after, as filed 10b5-1 plan filing $388K
  2. ANIPSold: ANI PHARMACEUTICALS INC Sep 15, 2026 5,400 shares filed Sep 16, 2026 339,089 shares held directly after, as filed 10b5-1 plan filing $383K
  3. ANIPSold: ANI PHARMACEUTICALS INC Aug 25, 2026 5,400 shares filed Aug 26, 2026 344,489 shares held directly after, as filed 10b5-1 plan filing $401K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.